Why the study?
Innovating valve materials compatible with the demanding conditions of catheter-based delivery in TAVI presents significant challenges.
Advances in polymer science and manufacturing techniques offer promising solutions to overcome the calcification and durability limitations of current biological TAVI valves.
Polymeric TAVI valves merit material optimization; leaves open prospective trials before any clinical consideration.
Transcatheter Aortic valve implantation (TAVI) procedure has been revolutionizing the Aortic Stenosis (AS) treatment over the last 20 years, because of its minimally invasive approach and fast postoperative recovery. However, innovation in valve material compatible with TAVI procedure present significant challenges, as they must endure the demanding conditions of catheter-based delivery. This review outlines the fundamental material requirements and challenges in the design and manufacturing of TAVI valves. It compares the existing TAVI devices made from animal tissues and polymers, and identifies the key factors that are limiting their adoption for widespread clinical use. While biological valves remain the predominant choice in current clinical TAVI practice, major future innovation is likely to arise from advances in polymer science aimed at overcoming the key limitations like calcification and limited durability. Fully polymeric valve systems are still at an early stage of development, but they hold considerable long-term potential due to their tunable mechanical properties, resistance to calcification, and potential for scalable manufacturing, that could revolutionize the field. ToC Figure
No takes yet. Share an insight, caveat, or question.
Dorishetty et al. (2026) conducted a review in Aortic Stenosis. Transcatheter Aortic Valve Implantation (TAVI) materials was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: